Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Feugier

Showing results (31-40 of 164) with videos related to

Pageof 17
Sort By:
American Journal of Hematology|April 26, 2017
Real-world results of ibrutinib in relapsed/refractory CLL in France: Early results on a large series of 428 patientsLoic Ysebaert, Thérèse Aurran-Schleinitz, Caroline Dartigeas, et al.
British Journal of Haematology|October 23, 2024
Conditional survival of younger patients with mantle cell lymphoma: Results from a randomized phase III trial of the European MCL NetworkLinmiao Jiang, Martin Dreyling, Olivier Hermine, et al.
Haematologica|November 13, 2008
High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: long-term resultsAngelo Michele Carella, Monica Bellei, Pauline Brice, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 15, 2004
Intravascular bone marrow accumulation in persistent polyclonal lymphocytosis: a misleading feature for B-cell neoplasmPierre Feugier, Anne Kennel De March, Jean F Lesesve, et al.
Transfusion|June 26, 2003
Hematologic recovery after autologous PBPC transplantation: importance of the number of postthaw CD34+ cellsPierre Feugier, Daniele Bensoussan, Florence Girard, et al.
Hepatology (Baltimore, Md.)|April 2, 2003
Primary lymphoma of the liver: clinical-pathological features and relationship with HCV infection in French patientsJean-Pierre Bronowicki, Catherine Bineau, Pierre Feugier, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 4, 2012
Ten-year relative survival and causes of death in elderly patients treated with R-CHOP or CHOP in the GELA LNH-985 trialNicolas Mounier, Natacha Heutte, Catherine Thieblemont, et al.
Blood|March 3, 2017
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association reportMira Tout, Olivier Casasnovas, Michel Meignan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Obinutuzumab (GA101) monotherapy in relapsed/refractory diffuse large b-cell lymphoma or mantle-cell lymphoma: results from the phase II GAUGUIN studyFranck Andre Morschhauser, Guillaume Cartron, Catherine Thieblemont, et al.
Annals of Hematology|October 13, 2025
Correction to: Real-world efficacy and safety outcomes of acalabrutinib in chronic lymphocytic leukemia: primary results of a French multicentre observational study (NAOS)Anne Quinquenel, Stéphane Leprêtre, Marie Sarah Dilhuydy, et al.
Pageof 17

Showing results (31-40 of 164) with videos related to

Sort By:
Pageof 17
American Journal of Hematology|April 26, 2017
Real-world results of ibrutinib in relapsed/refractory CLL in France: Early results on a large series of 428 patientsLoic Ysebaert, Thérèse Aurran-Schleinitz, Caroline Dartigeas, et al.
British Journal of Haematology|October 23, 2024
Conditional survival of younger patients with mantle cell lymphoma: Results from a randomized phase III trial of the European MCL NetworkLinmiao Jiang, Martin Dreyling, Olivier Hermine, et al.
Haematologica|November 13, 2008
High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: long-term resultsAngelo Michele Carella, Monica Bellei, Pauline Brice, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 15, 2004
Intravascular bone marrow accumulation in persistent polyclonal lymphocytosis: a misleading feature for B-cell neoplasmPierre Feugier, Anne Kennel De March, Jean F Lesesve, et al.
Transfusion|June 26, 2003
Hematologic recovery after autologous PBPC transplantation: importance of the number of postthaw CD34+ cellsPierre Feugier, Daniele Bensoussan, Florence Girard, et al.
Hepatology (Baltimore, Md.)|April 2, 2003
Primary lymphoma of the liver: clinical-pathological features and relationship with HCV infection in French patientsJean-Pierre Bronowicki, Catherine Bineau, Pierre Feugier, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 4, 2012
Ten-year relative survival and causes of death in elderly patients treated with R-CHOP or CHOP in the GELA LNH-985 trialNicolas Mounier, Natacha Heutte, Catherine Thieblemont, et al.
Blood|March 3, 2017
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association reportMira Tout, Olivier Casasnovas, Michel Meignan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Obinutuzumab (GA101) monotherapy in relapsed/refractory diffuse large b-cell lymphoma or mantle-cell lymphoma: results from the phase II GAUGUIN studyFranck Andre Morschhauser, Guillaume Cartron, Catherine Thieblemont, et al.
Annals of Hematology|October 13, 2025
Correction to: Real-world efficacy and safety outcomes of acalabrutinib in chronic lymphocytic leukemia: primary results of a French multicentre observational study (NAOS)Anne Quinquenel, Stéphane Leprêtre, Marie Sarah Dilhuydy, et al.
Pageof 17